MELD-Na score may underestimate disease severity and risk of death in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)
Abstract Portal hypertension often precedes the development of advanced fibrosis in patients with Metabolic dysfunction-associated steatotic liver disease (MASLD) and may accelerate disease progression to cirrhosis. We aimed to evaluate whether prioritization tools accurately predict survival in pat...
Guardado en:
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Nature Portfolio
2023-12-01
|
| Colección: | Scientific Reports |
| Acceso en línea: | https://doi.org/10.1038/s41598-023-48819-6 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|